The features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  van de Sande, Marleen G H ^a   de Hair, Maria J H ^a   Schuller, Yvonne ^a   van de Sande, Gijs P M ^a   Wijbrandts, Carla A ^a   Dinant, Huib J ^a   Gerlag, Danielle M ^a   Tak, Paul P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT BIOPSY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PATIENT CODING; PLASMA CELL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; VASCULARIZATION; BLOOD VESSEL; EUROPE; HEALTH CARE ORGANIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PROGNOSIS; STANDARD; TIME; WESTERN HEMISPHERE;

AMERICAS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD VESSELS; COHORT STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; SOCIETIES; SYNOVIAL MEMBRANE; TIME FACTORS;

EID: 84860522980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036668     Document Type: Article

References (27)

1. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, et al. (2008) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 58: S126-S135.
2. Finckh A, Liang MH, van Herckenrode CM, de Pablo P, (2006) Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 55: 864-872.
3. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann, et al. (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43: 906-914.
4. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM, (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46: 357-365.
5. van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, et al. (2007) A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 56: 433-440.
6. van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastian H, et al. (2008) Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 58: 2241-7.
7. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, et al. (1999) Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) 38: 1074-1080.
8. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588.
9. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569-2581.
10. Cader MZ, Filer A, Hazlehurst J, de Pablo P, Buckley CD, et al. (2011) Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis.
11. van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH, (2011) Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 63: 37-42.
12. de Hair MJ, Lehman KA, van de Sande MG, Maijer KI, Gerlag DM, et al. (2012) The clinical picture of rheumatoid arthritis according to the 2010 ACR/EULAR criteria: Is this still the same disease?, Arthritis Rheum. 64: 389-93.
13. de Hair MJ, Harty L, Gerlag DM, Pitzalis C, Veale D, et al. (2011) Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in early arthritis patients., J.Rheumatology 38: 2068-72.
14. van de Sande MG, Gerlag DM, Lodde BM, van Baarsen LG, Alivernini S, et al. (2011) Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis 70: 423-427.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
16. van der Heijde DM, (1999) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 26: 743-745.
17. Gerlag D, Tak PP, (2005) Synovial biopsy. Best Pract Res Clin Rheumatol 19: 387-400.
18. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJ, et al. (1995) Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 38: 1457-1465.
19. Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, et al. (2003) Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 62: 635-638.
20. Kraan MC, Haringman JJ, Ahern MJ, Breedveld FC, Smith MD, et al. (2000) Quantification of the cell infiltrate in synovial tissue by digital image analysis. Rheumatology (Oxford) 39: 43-49.
21. Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, et al. (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64: 834-838.
22. van der Hall PO, Kraan MC, Tak PP, (2007) Quantitative image analysis of synovial tissue. Methods Mol Med 135: 121-143.
23. Cantaert T, Kolln J, Timmer T, van der Pouw Kraan TC, Vandooren B, et al. (2008) B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 181: 785-94.
24. Thurlings RM, Wijbrandts CA, Mebius RE, Cantaert T, Dinant HJ, et al. (2008) Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum 58: 1582-1589.
25. Canete JD, Celis R, Moll C, Izquierdo E, Marsal S, et al. (2009) Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis 68: 751-756.
26. van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, et al. (2008) Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 58: 53-60.
27. Gerlag DM, Tak PP, (2007) How useful are synovial biopsies for the diagnosis of rheumatic diseases? Nat Clin Pract Rheumatol 3: 248-249.